BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. From Wikipedia
It is set to boost BioNTech’s mRNA cancer research contingent on securing regulatory approval.
